Human Primary Cells| 毕得医药

搜索购物车会员中心

含肽段连接子是一类包含特定序列短肽的连接子，这类酶可裂解连接子已广泛应用于抗体偶联药物（ADC）中。ADC的作用机制是借助抗体的靶向性被精准的输送到靶细胞，接着由内吞途径进入细胞内，由于细胞内的溶酶体存在高浓度的蛋白水解酶，从而为含肽链连接子提供了在细胞内选择性裂解的机会，最终可以实现有效载荷的控制性释放。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

用途： cBu-Cit Linkers (5) GGFG Linkers (8) Other Peptide Linkers (12) Val-Ala Linkers (8) Val-Cit Linkers (24)

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

默认常备现货
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg

清空选项

4-((2S,5S)-19-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7,17-trioxo-2-(3-ureidopropyl)-10,13-dioxa-3,6,16-triazanonadecanamido)benzyl (4-nitrophenyl) carbonate: BD008566122112738-13-198%; ￥12467.001g

Azido-peg4-val-cit-pab-oh: BD008124702055024-64-998%; ￥12747.001g

4-((14S,17S)-1-Azido-14-isopropyl-12,15-dioxo-17-(3-ureidopropyl)-3,6,9-trioxa-13,16-diazaoctadecan-18-amido)benzyl (4-nitrophenyl) carbonate: BD011112932055047-18-098%; ￥7720.0050mg

4-((S)-2-((S)-2-(3-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethoxy)propanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl (4-nitrophenyl) carbonate: BD012020302249935-92-896%; ￥15783.00100mg

BCN-PEG3-VC-PFP Ester: BD011924472353409-45-596%; ￥13937.00100mg

(S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanoic acid: BD01442568916746-27-598%; ￥2442.00250mg

(5-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoyl)-L-valyl-L-arginine: BD014390972504147-59-395%; ￥5815.00100mg

Mal-amido-PEG2-Val-Cit-PAB-OH: BD014237902504147-53-795%; ￥8953.00100mg

1 2